Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013)

Clinical trial NCT04939428 · COMPLETED

Trial details

NCT number: NCT04939428
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Coronavirus Disease (COVID-19)

Start date: 2021-08-11
Primary completion: 2022-11-16
Enrollment: 2441

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.